Skip to content
10-K

Annual Report

EXELIXIS, INC. EXEL

0000939767-25-000019

← back to feed
Filed
Feb 11, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 3, 2025 279.88M sh
Cash And Equivalents FY 2024 · Dec 29, 2023 $262.99M
Current Liabilities FY 2024 · Dec 29, 2023 $394.28M
Total Liabilities FY 2024 · Dec 29, 2023 $678.45M
Current Assets FY 2024 · Dec 29, 2023 $1.32B
Total Assets FY 2024 · Dec 29, 2023 $2.94B
Shares Diluted FY 2024 · Dec 30, 2022 324.56M sh
Stock Repurchased FY 2024 · Dec 30, 2022 $0
Capex FY 2024 · Dec 30, 2022 $27.71M
Operating Cash Flow FY 2024 · Dec 30, 2022 $362.61M
Eps Diluted FY 2024 · Dec 30, 2022 $0.56
Eps Basic FY 2024 · Dec 30, 2022 $0.57
Sga Expense FY 2024 · Dec 30, 2022 $459.86M
Rd Expense FY 2024 · Dec 30, 2022 $891.81M
Net Income FY 2024 · Dec 30, 2022 $182.28M
Operating Income FY 2024 · Dec 30, 2022 $201.48M
Cost Of Revenue FY 2024 · Dec 30, 2022 $57.91M
Revenue FY 2024 · Dec 30, 2022 $1.61B
Stockholders Equity FY 2024 · Dec 31, 2021 $2.21B